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Axons damaged by acute injury, toxic insults, or neurodegenera-
tive diseases execute a poorly defined autodestruction signaling
pathway leading to widespread fragmentation and functional
loss. Here, we describe an approach to study Wallerian degener-
ation in the Drosophila L1 wing vein that allows for analysis of
axon degenerative phenotypes with single-axon resolution in
vivo. This method allows for the axotomy of specific subsets of
axons followed by examination of progressive axonal degenera-
tion and debris clearance alongside uninjured control axons. We
developed new Flippase (FLP) reagents using proneural gene pro-
moters to drive FLP expression very early in neural lineages. These
tools allow for the production of mosaic clone populations with
high efficiency in sensory neurons in the wing. We describe a col-
lection of lines optimized for forward genetic mosaic screens using
MARCM (mosaic analysis with a repressible cell marker; i.e., GFP-
labeled, homozygous mutant) on all major autosomal arms (∼95%
of the fly genome). Finally, as a proof of principle we screened the
X chromosome and identified a collection eight recessive and two
dominant alleles of highwire, a ubiquitin E3 ligase required for axon
degeneration. Similar unbiased forward genetic screens should help
rapidly delineate axon death genes, thereby providing novel poten-
tial drug targets for therapeutic intervention to prevent axonal and
synaptic loss.
neurodegeneration | glial response
Widespread axonal degeneration and synapse loss occursduring neurodegenerative disease and after neural trauma.
These degradative events result in disruption of neural circuit
connectivity and ultimately functional impairment of the nervous
system. Identifying molecular cascades that actively promote
axonal self-destruction is a key goal. However, despite decades of
work, remarkably little is known about the molecular pathways
that drive the degeneration of neurites or synapses in any context
(1, 2).
Axotomy-induced axon degeneration (termed Wallerian de-
generation, WD) serves as a useful model to study the mecha-
nisms of axonal self-destruction. When axons are severed, the
portion of the axon distal to the injury site and its synapses un-
dergo catastrophic fragmentation after a defined latent phase,
and the resulting debris is eventually cleared by surrounding glial
cells. The discovery of the spontaneous Wallerian degeneration
slow (WldS) mouse revealed, surprisingly, that severed axons can
in fact survive for weeks in the absence of a cell body (3). It also
led to the proposal that “axon death” signaling cascades might
exist, akin to apoptotic cell death programs, which actively drive
the destruction of the axon (4).
Interestingly, WldS provides significant suppression in mouse
models of progressive motor neuron disease and glaucoma (5–8),
and moderate protection from chemotherapy-induced axon de-
generation (9). These observations argue that defining the mo-
lecular mechanisms of axon degeneration in the context of WD
could have an important therapeutic impact on the treatment of
neurological disorders.
WD has not been subjected to comprehensive forward genetic
screens, despite the fact that such approaches in model organisms,
including Drosophila melanogaster and Caenorhabditis elegans,
were critical for defining cellular degradation signaling pathways,
such as autophagy (10) and apoptosis (11). Recently, we described
the first forward genetic screen for loss-of-function mutations
capable of blocking WD in Drosophila, and identified the kinase
scaffolding molecule dSarm/Sarm1 (sterile alpha/Armadillo/Toll-
interleukin receptor homology domain protein) as essential for
WD in both the fly and mouse in vivo (12). Thus, unbiased genetic
screens in Drosophila can lead to the identification of key genes
required for mammalian axon degeneration after injury. This
point is further supported by the recent discovery of the E3
ubiquitin ligase Highwire/Phr1, which is required for WD (13, 14).
The labor-intensive nature of current screens is a critical and
limiting factor in identifying additional WD genes (F2 loss-
of-function, dissections, immunohistochemistry, and so forth). Here,
we describe a powerful forward genetic mosaic approach to identify
loss-of-function mutations that suppress WD/axon death signal-
ing. Our method also uses the Drosophila wing (15), but allows
for axotomy and visualization of single axons, and the use of F1
forward genetic screening approaches. The collection of tools we
describe should prove extremely useful in defining the molecular
mechanisms of axon degeneration and we envision many addi-
tional uses in exploring the basic biology of the axon in vivo.
Results
Visualizing WD with Single-Axon Resolution in the L1 Wing Vein. To
rapidly screen for mutants defective in axon degeneration, we
sought to develop an in vivo system that contains the following
characteristics: (i) rapid observation of individual axons (rather
than an entire axon bundle) with minimal dissection; (ii) the
opportunity to sever only a subset of axons so that one could
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observe axon death alongside healthy, uninjured axons; and (iii)
the ability to initiate and visualize axon death without killing the
fly (e.g., thereby allowing for F1-based mutagenesis screens).
These criteria led us to explore the Drosophila nerve housed in
the marginal (L1) wing vein, which contains both sensory neu-
rons and glia (Fig. 1 and Fig. S1; see also below).
When screening through a number of peripheral nervous
system Gal4 drivers, we identified candidate OK371-Gal4, which
labels ∼40 glutamatergic sensory neurons in the wing (Fig. 1A)
(16). The cell bodies of neurons expressing OK371-Gal4 are
aligned along the length of the L1 vein (arrow in Fig. 1A), and
project their axons within the L1 vein into the thorax. Some of
these axons project through the entire wing and are among the
longest axons in Drosophila (17). We focused our imaging of
these axons in a region of the L1 vein immediately posterior to
the costal vein (Fig. 1A, Inset). Hereafter, we will refer to this
region as the proximal L1 vein.
The L1 vein allows for a graded level of axotomy, which results
in two populations of axons: severed axons, whose cell bodies are
distal to the injury site; and intact axons, whose cell bodies are
proximal to the injury site. Axotomies were performed with
nonlethal surgical cuts through the middle of the L1 vein with
microdissection scissors in one wing; the other wing served as an
age-matched uninjured control (Fig. 1B). Flies were then placed
back in vials for 0–7 d. Eventually, both wings were removed, and
imaged by confocal microscopy (Fig. 1C). To determine the
number of uninjured axons, we counted the number of residual
cell bodies that remained in the proximal region of the injured
wing. We found that 100% of the severed axons initiated WD
(i.e., fragmentation) within 1 d postaxotomy (dpa), and that all
axonal debris was absent from the L1 vein by 7 dpa (Fig. 1 C and
D). In contrast, uninjured axons remained morphologically intact.
Conserved Molecular Mechanisms Modulate WD in the L1 Wing Vein.
We reasoned that if the L1 wing vein nerve was to be a useful
model to study WD, similar molecular programs should be in
place as observed in other Drosophila or mouse axotomy models
including protection by WldS (18, 19). WldS expression levels
correlate with protection/conservation in severed axons, where
high levels of WldS result in strong protection (18). Recently,
work by Fang et al. showed that axon degeneration in different
wing sensory neurons are protected by WldS (15). We tested the
glutamatergic neurons for their sensitivity to WldS by either
strongly (5×UAS) overexpressing WldS or an enzymatically im-
paired version, WldS(dead) (20), or by low level (1×UAS) expres-
sion of WldS (Fig. 1E, strong, intermediate, and mild protection,
respectively). Whereas GFP+ axonal debris was absent from sev-
ered wild-type axons from the L1 vein at 7 dpa (Fig. 1E, wild-type
control), we found graded protection levels ranging from strong
protection by high levels of WldS (i.e., many severed but intact
axons): intermediate protection by high levels of WldS(dead)
and mild protection by low levels of WldS (where fragmentation in
severed axons had already occurred, but axonal debris was not yet
fully cleared). These observations support the model of a dosage-
dependent protection by WldS of wing sensory neurons, similar
to what has been described in mouse (18). Moreover, our pro-
duction of the 1× WldS construct demonstrates the wing can
serve as a sensitized system in which to screen for modifiers of
WldS neuroprotection in vivo.
We also confirmed that programmed cell death is not involved
in WD in the wing vein, as neuronal-specific overexpression of
P35, a broad apoptosis inhibitor in Drosophila (21), did not alter
the rate of axon degeneration at 7 dpa (Fig. 1E, apoptosis-
defective). Local engulfing cells were required for active clearance
of axonal debris: we assayed homozygous viable draper mutant
animals [where clearance of axonal debris in the CNS is fully
impaired after olfactory receptor neuron (ORN) ablation (19)],
and found that GFP+ axonal debris persisted at 7 dpa at similar
signal intensities as compared side-by-side to an intact axon
(arrowhead in Fig. 1E, engulfment-defective). Thus, Draper-
dependent signaling mechanisms are required for efficient
clearance of axonal debris in the L1 vein.
Glial Cells in the L1 Wing Vein Are Diverse and Engulf Axonal Debris.
The most likely candidate cell types executing engulfment of
axon debris are local glial cells, which are known to reside in the
Drosophila wing (22). To explore the morphological and func-
tional diversity of glial subtypes in the L1 vein, we combined
Fig. 1. WD is molecularly conserved in the marginal vein. (A) OK371-Gal4–labeled glutamatergic sensory neurons along the anterior wing margin project
their axons through the anterior wing margin toward the thorax, through the L1 vein [arrow, individual cell body (cb); box and Inset indicate the L1 vein,
posterior to the costal vein]. Anterior, Upper; medial, Left. (B) Schematic axotomy assay. A unilateral lesion in the wing results in two populations of axons:
severed axons, whose cell bodies (indicated as green dots) are distal to the injury site; and intact axons, whose cell bodies are proximal to the injury site
(dashed line). After the desired day postaxotomy, the severed wing is separated from the thorax for immediate microscopic analyses. A simplified illustration
of axotomy on serially aligned sensory neurons is indicated below. The number of uninjured cell bodies is indicated in the upper right corner. (C) Example of
axons undergoing axon death. Uninjured control axons, as well as severed axons at 5 dpa and 7 dpa (Top to Bottom, respectively). Over time, all severed axons
undergo fragmentation and the resulting axonal debris will be cleared alongside uninjured control axons. (D) Axon death time course. (E) WD is molecularly
conserved in the L1 vein: From left to right: wild-type axons at 7 dpa. Strong protection of severed axons is mediated by high overexpression (5×UAS) of WldS,
whereas similar overexpression of WldS(dead), an enzymatic impaired version, results in a partial protection. Low levels of WldS (1×UAS) result in a weak axon
death protection. The inhibition of apoptosis by overexpression of P35 fails to protect severed axons. Animals homozygous mutant for the engulfment
receptor draper fail to clear axonal debris. (Scale bars, 5 μm.) Genotypes are listed in SI Materials and Methods.
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a number of Gal4- and LexA-based drivers, as well as GFP traps
that label specific subsets of Drosophila glial cells (23–25). We
also took advantage of another binary expression system and
generated a number of new QF/QUAS-based tools to differen-
tially label axons and glia side-by-side (Fig. 2A, Fig. S2, and
see below).
To examine the histological relationship between neurons and
glia, we first labeled all glia (pan-glial driver repo-LexA) and
found the entire L1 vein was fully covered by glial membranes
(Fig. 2B, Top). Glial cells could be divided into two main sub-
types: wrapping glia (nrv2-GFP protein trap) that ensheath axons
directly, and subperineurial glia (rL82-Gal4) that surround both
axons and wrapping glia (Fig. 2B, Middle and Bottom). To ap-
proximate the density of cells within these populations, we drove
a nuclear marker in individual glial subtypes and counted the
number of nuclei (Fig. 2 C and D). Wrapping glial nuclei were
found at a density of 2.6/100 μm, subperineurial glia at 4.1/100
μm, and total glial density was 6.6/100 μm. We suspect that these
subsets represent the complete complement of glia in the L1
vein, as the sum of ensheathing and subperineurial glial nuclei is
comparable to the number found when all glial nuclei were la-
beled (Fig. 2 C and D).
To determine whether glial cells engulfed axonal debris after
axotomy we used RNAi-mediated knockdown of draper using
glial-specific Gal4 drivers (Fig. 2 E and F). Depleting Draper from
all glia suppressed clearance of axonal debris at levels equivalent
to those found in homozygous draper-null mutants at 7 dpa.
Knockdown of draper in wrapping glial also resulted in a strong
suppression of clearance of axonal debris, whereas knockdown in
subperineurial glia had a much more modest effect (Fig. 2 E and
F). Thus, glial cells—and in particular wrapping glia—are the key
cell type required for clearance of axonal debris in the L1 wing
vein. This tissue represents a histologically simple system in which
to visualize axonal degeneration and neuron-glia interactions after
injury with high cellular resolution (Fig. 2G).
A Tool Kit for Rapid Genome-Wide Forward Genetic Screens with
Single-Axon Resolution. The observation of fine axonal struc-
tures within an axon bundle where 40 axons are labeled is chal-
lenging. Ideally one would label individual axons. We therefore
combined the above-described Gal4-based makers for subsets of
glutamatergic neurons with mosaic analysis with a repressible cell
marker (MARCM) (26). First, we optimized heat-shock–trig-
gered Flippase expression (hs-FLP), which was sufficient to
generate GFP+MARCM clones with single-axon resolution (Fig. 3
A and B and Fig. S3). Based on these initial hs-FLP analyses, we
concluded that labeling between three and five axons was optimal
for visualizing axonal degeneration. Next, we cloned several pro-
moters of proneural genes: we reasoned that these promoters were
highly active during wing sensory neuron development to help
pattern sensory organ precursors (SOPs), and therefore they could
be excellent candidates for specific FLP expression (Fig. S4 A and
B). We created transgenic flies harboring three different SOP
candidate promoter-FLP transgenes: senseless-FLP (sense-FLP),
achaete-FLP and asense-FLP (ase-FLP), and extramacrochaetae-
FLP (emc-FLP), which is broadly active in epithelial cells before
proneural cluster determination, thus less specific to SOP line-
ages (Table S1).
We prescreened these transgenic stocks to determine cell-type
FLP activity (i.e., neurons, glia, or epithelial cells), and rescreened
promising candidates for their relative strength in FLP activity in
glutamatergic neurons (Fig. S4C). hs- and emc-FLP sources con-
tained strong and broad (e.g., glial, neuronal, and epidermal)
activity, whereas both sense-FLP and achaete-FLP harbored weak,
but restricted activity to neurons. However, ase-FLP2a and ase-
FLP3a (inserted on chromosomes 2 and 3, respectively) contained
strong neuronal activity (Fig. S4C). We therefore decided to test
ase-FLP2a in a MARCM background for both arms of chromo-
some 3. ase-FLP2a was sufficient to induce GFP-labeled clones,
and the induction of clone numbers was not only dependent on
the chromosomal arm used for MARCM (1.2 ± 0.9 vs. 5.2 ± 1.7,
FRT2A vs. FRT82B, respectively, in Table S2), but also on the
copy number of ase-FLP2a, because increased dosage of ase-FLP
leads to the production of increased numbers of MARCM clones
in L1 wing vein sensory neurons (Fig. S5).
Transgene activity in the Drosophila genome is influenced by
the genomic area surrounding the transgene insertion site. We
therefore mobilized ase-FLP2a and ase-FLP3a to create random
ase-FLP insertions. These insertions were screened in a MARCM
background to ultimately determine “optimally” paired FLP-
sources and FRT lines with which one could generate reliably high
(∼5) or low (1 or 2) MARCM clone induction rates, using any
major chromosome arm (Fig. 3 C and D). Each newly isolated
FLP source was tested in a MARCM assay (chromosomes 3, 2,
and X in Tables S2, S3, and S4, respectively). This established
collection of tools allows for genetic access to the vast majority of
the Drosophila genome for studies of axon degeneration or basic
axon biology using the L1 wing vein.
The ability to label individual axons with GFP in the intact
wing allowed us to observe fine structural changes in axonal
Fig. 2. Neuro-glio morphology in the Drosophila L1 vein. (A) Only a minor
subset of all axons is glutamatergic in the L1 vein. Colabeling of all sensory
neurons (elaV-Gal4) and glutamatergic neurons (VGlut-QF). (B) Axons in the
L1 vein are surrounded by two glial subtypes. (Top) Colabeling of glia and
glutamatergic axons. (Middle) Wrapping glia ensheath axons. (Bottom)
Subperineurial glia form a tube around wrapping glia and axons. (C and D)
The repo-positive tubular L1 vein structure consists primarily of wrapping
and subperineurial glia, as determined by nuclei scores. The sum of nuclei
per 100 μm labeled by wrapping and subperineurial glial drivers (2.6 ± 0.9
and 4.1 ± 1.4, respectively) resembles the nuclei number of all glia (6.6 ± 1.7).
Asterisks, cross sections. Data: average ± SD. (E and F) Clearance of axonal
debris is mainly performed by wrapping glia. (E) RNAi-mediated Draper
knockdown in glia results in three distinguished phenotypes: cleared, partial,
and defective (white, light gray, and dark gray, respectively; used in F).
(Scale bars, 5 μm.) (F) Quantification of engulfment efficiency (n = 20 wings
each). (G) Schematic L1 vein morphology. Subperineurial glia (dark gray)
form a tube around wrapping glia (gray), which ensheath glutamatergic and
other axons (green and light gray, respectively). Genotypes are described in
SI Materials and Methods.
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integrity over time after axotomy, and compare them to un-
injured control axons in the same preparation (Fig. 3 E and F).
Within 6 h postaxotomy (hpa), 42% of all severed axons (n ≥ 60)
underwent morphological changes that included the formation
of spheroids [i.e., local swellings or focal axonal degeneration
(27)] and the first signs of fragmentation (Fig. 3E, arrow). At 12
hpa, severed axons began to lose their integrity and contained
discontinuous axon shafts, whereas control axons remained
morphologically intact. This time course supports previous
findings (19), but allows for the unambiguous scoring of break-
down of the integrity of even single axons.
WD in Wing Sensory Neurons Requires dsarm. To determine whether
axon degeneration in the L1 vein was dSarm-dependent, we
generated dsarm mutant MARCM clones in the wing. Whereas in
wild-type all severed axons underwent fragmentation and were
cleared from the vein by 7 dpa, we found that severed dsarm axons
remained intact and were morphologically indistinguishable from
adjacent uninjured dsarm axons or control axons (Fig. 4 A and B).
Thus, axon death in the L1 vein requires dsarm function, similarly
to sensory neurons in antennae, and multiple neuronal subtypes in
mammals (12).
The wing allowed us also to carefully quantify the persistence
of severed but intact dsarm axons by counting the number of cell
bodies (i.e., axons that are severed) in the cut off wing: we found
that 100% of all severed dsarm axons remained intact at 7 dpa,
compared with 0% in wild-type (Fig. 4C). Thus, severed axons
remain fully protected in dsarm mutants, at least for 7 d.
Rapid Identification of Dominant and Recessive highwire Alleles
Through Forward Genetic Screens in the Wing. To test the effi-
ciency of the wing as a screening tool, we ethyl methane sulpho-
nate (EMS)-mutagenized ∼1,500 X chromosomes, and screened
those for mutants defective in axon degeneration. We identified
several mutants exhibiting potent protection of severed axons at
7 dpa (Fig. 5A). For example, all severed x052 mutant axons
remained morphologically intact and undistinguishable from
uninjured control axons at 7 dpa (Fig. 5 B and C). To determine
whether x052 mutants could also protect other Drosophila axons,
we axotomized ORNs (19). Unilateral antennal ablation resulted
in axon degeneration and debris removal of wild-type ORN
axons within 10 d (Fig. 5D, arrow); however, intact severed x052
clones were observed at 10, 30, and even 50 dpa.
To identify the molecular nature in x052 responsible for the
axon protective phenotype, we used the Drosophila GEM.app
whole-genome sequencing analysis approach followed by com-
plementation tests (28). Through this approach, we identified
a premature stop in codon 2791 (CAG → TAG) of the highwire
locus, which has recently been shown to be required for axon
degeneration (13). We tested for allelism by performing com-
plementation tests using a large N-terminal deletion allele of hiw
termed hiwΔN (29). At 1 dpa, severed wild-type and heterozygous
Fig. 3. Genome-wide clonal tool for analyses at single-axon resolution. (A)
Examples of heat-shock–induced hs-FLP MARCM axon clones. (Top) GFP+
glutamatergic axon bundle. (Middle and Bottom) Examples of five and two
MARCM clones, respectively. Cross-sections are shown on the right. Heat-
shock treatment is shown in Fig. S3. (B) Distribution of heat-shock–induced
MARCM clones (chromosome X, FRT19A). Dots indicate clone numbers per
wing (n = 30). (C) Examples of ase-FLP MARCM clones on chromosomes 3L
and 3R. Detailed distribution is shown in Fig. S5. (D) ase-FLP sources as a tool
for genome-wide clonal analysis. ase-FLP source and Gal4 driver combinations
induce many or few clones on each chromosomal arm. Individual ase-FLP
activity is listed in Tables S2–S4. Data are shown as average ± SD (n = 24). (E)
Onset of axon death at single-axon resolution. Examples of uninjured (ctl), as
well as injured axon clones 6 and 12 hpa side-by-side of healthy axons, re-
spectively (arrows, pronounced blebbing, swelling, and loss of axonal integrity,
respectively). (F) Quantification of severed axons undergoing degeneration (n ≥
60). (Scale bars, 5 μm.) Genotypes are described in SI Materials and Methods.
Fig. 4. dsarm is required for axon death in the wing. (A) Examples of wild-
type and dsarmmutant axon clones, uninjured and 7 dpa, respectively. (Scale
bar, 5 μm.) (B) Quantification of attached cell bodies and axons (gray and
white, respectively) in uninjured control and 7-dpa wings. Data are shown as
average ± SEM (n = 24). (C) Potent protection of severed axons in dsarm
mutant clones at 7 dpa. First, the number of cut off cell bodies was de-
termined, and then remaining cell bodies/axons scored at 7 dpa. Shown is
the percentage of severed axons of wild-type and dsarm mutants that re-
main morphologically intact a 7 dpa. Genotypes are described in SI Materials
and Methods.
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mutant axons underwent catastrophic fragmentation; however,
hiwΔN/x052 axons remained morphologically intact, even at 7 dpa
(Fig. 5E). Furthermore, severed x052 clones coexpressing the
cDNA of either hiw or gfp::hiw fragmented and their debris was
cleared within 7 dpa (Fig. 5 F and G). Taken together, these data
suggest that x052 is an allele of highwire.
Surprisingly, we identified a total of 10 hiw alleles in the same
screen (by similar procedures as described above): hiw157, hiw052,
hiw587, hiw352, hiw403d, hiw275d, and hiw022, where the molecular
nature was identified, and three alleles, hiw213, hiw649, and hiw704,
where the molecular lesion was not determined (Fig. 5H). High-
wire belongs to the family of RING domain E3 ubiquitin ligases,
where the E3 RING domain is involved in the direct transfer of
ubiquitin (Ub) from E2∼Ub complex to the target substrate (30).
Unexpectedly, we found that two alleles, hiw403d and hiw275d,
dominantly suppressed axon degeneration (Fig. 5I). Interestingly,
genome sequencing revealed that both hiw403d and hiw275d contain
mutations in or close to the Ring domain (Fig. 5H). These data
argue that specific loss of the Hiw Ring domain—which would
lead to a protein predicted to bind its substrate but not transfer
ubiquitin—can dominantly suppress axon degeneration. Consis-
tent with this notion, Gal4/UAS-mediated overexpression of
Highwire containing a nonfunctional RING domain (HiwΔRING)
in wild-type animal phenocopies loss of hiw function both in NMJ
morphological defects and axon degeneration (13, 29). Our obser-
vation that both hiw403d and hiw275d fully suppress axon degeneration
for 1 wk after axotomy argues for a key role for the Hiw RING
domain in axon death signaling.
In summary, the above data show that forward genetic
MARCM screens in the Drosophila wing, coupled with whole-
genome resequencing, is an extremely efficient approach to
isolate axon death signaling genes and, in the case of EMS
mutagenesis, generate an allelic series that is informative re-
garding protein function.
Discussion
Our work helps to further establish Drosophila as a powerful in
vivo system in which to explore molecular pathways mediating
axon degeneration. Our collection of tools allows for labeling,
manipulation, and visualization of single axons in vivo. Individual
axons can be severed and the resulting onset and progression of
axon degeneration can be observed alongside uninjured neigh-
boring axons. This process allows for counting actual axon
numbers in vivo for very precise determination of levels of pro-
tection in different mutant backgrounds, rather than simply vi-
sualizing a large bundle of axons and scoring remaining GFP
intensity (15). When large bundles of GFP+ axons are visualized,
one cannot conclusively demonstrate that individual axons have
remained morphologically intact.
The newly generated FLP sources driven by the proneural
promoters are convenient tools to easily generate MARCM
clones early in neural lineages: our collection thus simplifies
forward genetic screens in a genome-wide manner. Importantly,
a rapid F1-based axon death phenotype screen in the wing
(without killing the fly) represents a significant improvement
over our previous F2-based approaches in the Drosophila olfac-
tory system (Fig. S6).
It is important to note that although it is a very useful tool
for screening, the wing vein is not ideal for some applications
essential for studying the cell biology of axons and glia: for ex-
ample, immunohistochemistry and electron microscopy ultra-
structural analysis, based on sectioning issues with a very thin
Fig. 5. Identification and characterization of recessive and dominant highwire alleles. (A) Isolation of axon death candidate x052. Examples of wild-type and
x052mutant clones, uninjured and 7 dpa, respectively. (B) x052 axon death phenotype quantification. Attached clonal cell bodies and axons (black and white,
respectively) were scored in uninjured control and 7-dpa wings. Data: average ± SEM (n ≥ 15). (C) Severed x052 clonal axons remain intact at 7 dpa. Detailed
description is in Fig. 4C. (D) Severed x052 axons remain intact for the lifetime of the fly. Wild-type and x052 ORN clones were unilaterally severed and an-
alyzed at indicated time points. Arrows indicate severed axons. (E) x052 is an allele of highwire (hiw). Wild-type, heterozygous hiwΔN, and x052, as well as
transheterozygous hiwΔN/x052 animals were subjected to axotomy as described in Fig. 1C. Axons of hiwΔN/x052 animals fail to undergo catastrophic frag-
mentation at 1 dpa, and axons remain intact at 7 dpa. (F) hiw rescues the x052 axon death phenotype. Coexpression of the cDNA of either hiw or gfp::hiw in
clonal x052 axons rescues the axon death phenotype. (G) Quantification of hiw rescue. The onset of fragmentation at 2 dpa was scored in indicated clonal
phenotypes. Data: average ± SD (n = 10 wings). (H) Molecular nature of isolated hiw mutant alleles. Amino acid position and codon change are indicated
beneath each allele. Three other alleles were not sequenced (hiw213, hiw649, and hiw704, respectively). (I) Isolation of two dominant hiw alleles. Severed axons
heterozygous for either hiw403d or hiw275d remain protected at 7 dpa. (Scale bars, 5 μm). Genotypes are described in SI Materials and Methods.
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nerve embedded within a thick cuticle. Nevertheless, the pro-
duction of additional markers for visualizing live axons, organ-
elles, or even proteins certainly allows for detailed visualization
of axonal biology in live or fixed preparations (31).
We also note that care must be taken when interpreting
phenotypes after L1 vein axotomy: transection of the marginal
vein not only severs axons, but also local glial cells. In some
cases, axonal debris persisted for over a week close to the injury
site, even in controls animals. We suspect this represents an in-
jury-induced impairment of glial engulfment function because of
degeneration, apoptosis, or necrosis of glia adjacent to the injury
site after axotomy. Indeed, we have observed cell bodies of
sensory neurons proximal to the injury site degenerating after
axotomy, probably because of local glial loss and, in turn, de-
generation of now naked, unsupported neuron cell bodies.
However, such problems can be avoided by cutting the wing
midway along the L1 nerve and then image axonal degeneration
in the most proximal region of the wing (box in Fig. 1A).
Finally, by performing a small-scale EMS pilot screen, fol-
lowed by whole-genome resequencing using the web-based
GEM.app tool (28), as well as rescue and complementation tests,
the wing allowed us to readily isolate several alleles of highwire,
a gene recently identified to be required for axon degeneration
both in Drosophila and in mammals (13, 14). Among these hiw
alleles, we isolated an early stop at coding position 1312 (hiw157,
K1312stop), as well as two dominant alleles that affect the RING
domain (hiw275d and hiw403d). Surprisingly, endogenous expres-
sion levels of one copy of hiw predicted to contain a mutation in
the RING domain was sufficient to provide potent protection to
severed axons. Thus, the Hiw RING domain is a key functional
domain required to drive axonal degeneration. It remains to be
determined how these dominant hiw alleles block axon de-
generation (13, 29).
Loss-of-function screens in the wing vein represent a powerful
approach to dissect the molecular basis of axon degeneration.
Axonal and synaptic degeneration is a hallmark of every neu-
rodegenerative disease and occurs in peripheral neuropathies
(1, 2), but mechanisms promoting axonal self-destruction remain
elusive. The identification of new genes that regulate axonal
degeneration will advance our fundamental knowledge of a basic
biological axon death process, and provide exciting new potential
drug targets for intervention in neurodegenerative disease.
Materials and Methods
See SI Materials and Methods for more information. SI Materials and
Methods contains detailed descriptions of the wing axotomy assay and
subsequent wing microscopy, the wing engulfment assay, and quantification
of axon degeneration. It also includes information about the ORN unilateral
ablation assay, brain dissection, EMS mutagenesis, and genome-wide se-
quence analyses.
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